The trends of an increased interest in RPM and potential cost savings have inspired companies to participate in this slowly evolving paradigm shift and improve technology

I work at Emory University in a multidisciplinary group that is employing medical technologies to improve our understanding of cardiovascular disease autonomic physiology and behavioral mechanisms. We incorporate measurements of physical activity, stress and sleep into our research.

May 5, 2022 – The American Society of Echocardiography (ASE), the largest global organization for cardiovascular ultrasound imaging professionals, will recognize eight award recipients at the

May 5, 2022 – Foldax, Inc. has announced that the first patients have been enrolled in the Drugs Controller General of India (DCGI)-approved clinical trial of the TRIA biopolymer surgical aortic heart valve. The TRIA valve reimagines the heart valve by combining the company’s proprietary biopolymer – LifePolymer – with an innovative valve design intended to resist calcification, withstand stresses and strains without failure, and restore patient quality of life without lifelong use of anticoagulants.

May 5, 2022 – Joe DiMaggio Children’s Hospital recently announced the successful treatment of a patient with atrial septal defects (ASD), or opening defect in the wall of the heart that separates the top two chambers of the heart, using the first transcatheter ASD occluder with a metal-free frame. The novel device has been implanted as part of the ASCENT ASD U.S.

May 5, 2022 — High-level results from the DELIVER Phase III trial showed AstraZeneca’s FARXIGA (dapagliflozin) reached a statistically significant and clinically meaningful reduction in the primary composite endpoint of cardiovascular (CV) death or worsening heart failure (HF).

May 5, 2022 – A new Yale-led study has for the first time identified which risk factors are more likely to trigger a heart attack or acute myocardial infarction (AMI) for men and women 55 years and younger.

Researchers discovered significant sex differences in risk factors associated with AMI and in the strength of associations among young adults, suggesting the need for a sex-specific preventive strategy. For example, hypertension, diabetes, depression, and poverty had stronger associations with AMI in women compared with men, they found.

May 5, 2022 – Cardiovascular disease is a group of conditions that can arise from a lack of physical activity, poor diet, or certain disorders. Scientists have known that the development of these conditions begins with changes in vascular endothelial cells - the cells that line the body’s blood vessels. But why and how changes in endothelial cell function occur is not entirely clear.  

May 5, 2022 – Survivors of serious stroke can reduce their chances of dying within the year by 76% if they complete a modified cardiac rehabilitation program that includes medically supervised exercise, prescribed therapy, and physician follow-up, according to new research published in the Journal of Stroke & Cerebrovascular Diseases. The findings have the potential to change the future of stroke care.

. Leading the charge are devices like the Eko smart stethoscope and the Tyto remote otoscope that allow clinicians to remotely auscultate patients’ hearts, lungs and abdomen, and see inside the ear. More devices will surely come, with the aim of replicating the in-office visit.

Before opining on the future of cardiac health, I think it’s important to define what “cardiac health” actually is. If one searches the internet for the term, the result is a cornucopia of self-promotion and advertising. Yes, some of the content is helpful, but mostly these are pitches for an individual’s or group’s services. Not particularly useful, in my opinion.
With the increase of patients experiencing heart failure and clinical challenges to manage advanced heart failure conditions, therapies with implantable devices have become an essential treatment method

The current standard of care for heart failure (HF) is guideline-directed medical therapy combined with device-based interventions in eligible patients. However, many patients experience progressive deterioration in their HF status that warrants additional intervention.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now